Potential Limitations of the World Health Organization Criteria for Nonsevere Tuberculosis in Children in a Low Prevalence, High-resource Setting
View abstract on PubMed
Summary
This summary is machine-generated.The World Health Organization
Area Of Science
- Pediatric infectious diseases
- Global health policy
- Tuberculosis research
Background
- The World Health Organization (WHO) updated pediatric tuberculosis disease (TBD) treatment guidelines in 2022.
- A 4-month treatment regimen for nonsevere TBD was recommended, based on a study in low-resource settings.
Purpose Of The Study
- To evaluate the applicability of WHO pediatric TBD guidelines in a high-resource setting.
- To assess the accuracy of TBD severity classification in a high-resource context.
Main Methods
- A retrospective cohort study analyzed pediatric TBD patients (<16 years) treated between 2010 and 2023.
- Patients were classified as nonsevere or severe TBD based on WHO criteria.
Main Results
- Of 159 patients, 104 (65.4%) were initially classified as nonsevere TBD.
- Further investigation revealed that 28 (26.9%) of these nonsevere cases showed signs of severe disease.
- Ultimately, 83 (52.2%) patients were reclassified as having severe TBD.
Conclusions
- WHO TBD guidelines may lead to underestimation of disease severity in high-resource settings.
- Incorrect TBD severity classification risks inadequate treatment and potential treatment failure.
Related Concept Videos
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
• Class zero: The individual has no known TB exposure and has a negative tuberculin skin test.
• Class one: The individual has been exposed to...
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

